Literature DB >> 10885428

Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.

A Imada1, N Shijubo, H Kojima, S Abe.   

Abstract

Angiogenesis is in part related to mast cells. However, the biological significance of mast cells within lung carcinoma remains unclear. Immunohistochemistry was used to stain for tryptase, CD34 and vascular endothelial growth factor (VEGF) in 85 cases of stage I nonsmall cell lung carcinoma. VEGF was found in 33 of 53 adenocarcinomas and 14 of 32 squamous cell carcinomas. Cases of adenocarcinoma had significantly higher mast cell counts than those of squamous cell carcinoma. In adenocarcinoma, mast cell counts in VEGF-positive tumours were significantly higher than in VEGF-negative tumours, whereas in squamous cell carcinoma they were not. Good correlation was observed between intratumoural mast cell counts and microvessel counts. Double staining showed most intratumoural mast cells expressed VEGF. Importantly, only in lung adenocarcinoma, members in the high mast cell count group had significantly worse prognosis than those in the low mast cell count group. It is concluded that tumour-released vascular endothelial growth factors may be related to mast cell accumulation, intratumoural mast cells may produce vascular endothelial growth factor, and stromal mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885428     DOI: 10.1034/j.1399-3003.2000.01517.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  53 in total

1.  Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice.

Authors:  Elizabeth F Redente; David J Orlicky; Ronald J Bouchard; Alvin M Malkinson
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer Vaccines.

Authors:  Adam Yagui-Beltrán; Lisa M Coussens; David M Jablons
Journal:  US Oncol       Date:  2009

3.  A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers.

Authors:  Eun-A Ko; Kenton M Sanders; Tong Zhou
Journal:  Oncoimmunology       Date:  2017-08-08       Impact factor: 8.110

Review 4.  Mast cells as regulators of adaptive immunity to tumours.

Authors:  A Wasiuk; V C de Vries; K Hartmann; A Roers; R J Noelle
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

5.  Prognostic value of tumor-infiltrating mast cells in outcome of patients with esophagus squamous cell carcinoma.

Authors:  Ashraf Fakhrjou; Seid Mahdi Niroumand-Oscoei; Mohamad Hosein Somi; Morteza Ghojazadeh; Shahnaz Naghashi; Shabnam Samankan
Journal:  J Gastrointest Cancer       Date:  2014-03

Review 6.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

Authors:  Aaron J Schetter; Niels H H Heegaard; Curtis C Harris
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

Review 7.  The dual role of complement in cancer and its implication in anti-tumor therapy.

Authors:  Ioannis Kourtzelis; Stavros Rafail
Journal:  Ann Transl Med       Date:  2016-07

8.  An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

Authors:  Ge Jin; Hameem I Kawsar; Stanley A Hirsch; Chun Zeng; Xun Jia; Zhimin Feng; Santosh K Ghosh; Qing Yin Zheng; Aimin Zhou; Thomas M McIntyre; Aaron Weinberg
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

9.  Mast cells and human hepatocellular carcinoma.

Authors:  Fabio Grizzi; Barbara Franceschini; Maurizio Chiriva-Internati; Young Liu; Paul L Hermonat; Nicola Dioguardi
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Effect of radiotherapy on expression of hyaluronan and EGFR and presence of mast cells in squamous cell carcinoma of the head and neck.

Authors:  Eva Lindell Jonsson; Karin Nylander; Lars Hallén; Göran Laurell
Journal:  Oncol Lett       Date:  2012-09-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.